Trial intelligence / Profile preview

Anakinra plus methotrexate in Chinese patients with active rheumatoid arthritis

ChiCTR-TRC-09000383Phase 3Completed

Sponsor
Xi-jing Hospital, the 4th Military Medical University, Shanghai Changzheng Hospital
Start
Jan 2008
Modality
Cytokines & Interferons → Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in rheumatoid arthritis (RA) comparing Placebo + methotrexate with Anakinra + methotrexate (2 arms). Primary endpoint: ACR score. Started Jan 2008; status: completed.

02

Drugs

anakinra
03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on ChiCTR-TRC-09000383.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-09000383.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call